Calliditas Therapeutics AB Comprehensive Income
Calliditas Therapeutics AB reported Comprehensive Income of -SEK 47.33 million for the 3-month period ending 2024-06-30, per its 6-K filed 2024-08-13.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2024-08-13
- Calliditas Therapeutics AB comprehensive income for the quarter ending 2024-06-30 was -47.33M SEK.
- Calliditas Therapeutics AB comprehensive income for the quarter ending 2023-06-30 was -96.53M SEK.
- Calliditas Therapeutics AB comprehensive income for the quarter ending 2022-06-30 was -159.98M SEK.
- Calliditas Therapeutics AB comprehensive income for the quarter ending 2022-03-31 was -206.95M SEK.
| Period end | Comprehensive Income 3 month | Comprehensive Income 3 month as first filed | Comprehensive Income 6 month | Comprehensive Income 6 month as first filed | Comprehensive Income 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -47.33M SEK 6-K · filed 2024-08-13 | -277.13M SEK 6-K · filed 2024-08-13 | |||
| 2023-12-31 | -483.79M SEK 6-K · filed 2024-08-13 | ||||
| 2023-06-30 | -96.53M SEK 6-K · filed 2024-08-13 | -283.56M SEK 6-K · filed 2024-08-13 | |||
| 2022-12-31 | -373.22M SEK 20-F · filed 2024-04-24 | ||||
| 2022-06-30 | -159.98M SEK 6-K · filed 2023-08-17 | -366.94M SEK 6-K · filed 2023-08-17 | |||
| 2022-03-31 | -206.95M SEK 6-K · filed 2022-05-20 | ||||
| 2021-12-31 | -527.65M SEK 20-F · filed 2024-04-24 | ||||
| 2021-06-30 | -168.05M SEK 6-K · filed 2022-08-19 | -167.11M SEK 6-K · filed 2021-08-20 | -293.23M SEK 6-K · filed 2022-08-19 | -285.90M SEK 6-K · filed 2021-08-20 | |
| 2021-03-31 | -125.18M SEK 6-K · filed 2022-05-20 | ||||
| 2020-12-31 | -444.65M SEK 20-F · filed 2023-04-26 | ||||
| 2020-06-30 | -61.38M SEK 6-K · filed 2021-08-20 | -125.04M SEK 6-K · filed 2021-08-20 | |||
| 2019-12-31 | -32.59M SEK 20-F · filed 2022-04-27 | ||||
| 2018-12-31 | -132.04M SEK 20-F/A · filed 2022-01-14 |